Dashboard
1
Poor Management Efficiency with a low ROCE of 12.82%
- The company has been able to generate a Return on Capital Employed (avg) of 12.82% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
With ROE of 1.75%, it has a Very Expensive valuation with a 3.51 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.62%
0%
-9.62%
6 Months
-4.53%
0%
-4.53%
1 Year
19.62%
0%
19.62%
2 Years
5.91%
0%
5.91%
3 Years
-13.21%
0%
-13.21%
4 Years
-46.56%
0%
-46.56%
5 Years
-11.84%
0%
-11.84%
Eurofins Scientific SE for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.64%
EBIT Growth (5y)
19.39%
EBIT to Interest (avg)
3.53
Debt to EBITDA (avg)
3.15
Net Debt to Equity (avg)
0.82
Sales to Capital Employed (avg)
0.11
Tax Ratio
19.70%
Dividend Payout Ratio
28.14%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
12.82%
ROE (avg)
18.36%
Valuation key factors
Factor
Value
P/E Ratio
200
Industry P/E
Price to Book Value
3.51
EV to EBIT
190.82
EV to EBITDA
123.78
EV to Capital Employed
2.13
EV to Sales
19.53
PEG Ratio
1.57
Dividend Yield
0.96%
ROCE (Latest)
1.12%
ROE (Latest)
1.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 4 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
6,951.00
6,514.60
6.70%
Operating Profit (PBDIT) excl Other Income
1,417.60
1,211.10
17.05%
Interest
141.70
118.70
19.38%
Exceptional Items
-10.90
-15.40
29.22%
Consolidate Net Profit
405.50
307.80
31.74%
Operating Profit Margin (Excl OI)
104.50%
83.90%
2.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 6.70% vs -2.94% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 31.74% vs -49.19% in Dec 2023
About Eurofins Scientific SE 
Eurofins Scientific SE
Miscellaneous
Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. It is active through Ahma Group, Villapharma, Exova's environment testing laboratories in Eastern Canada, ASL analises ambientais in Brazil, MVZ fur Laboratoriumsmedizin am Hygiene-Institut Gmbh, Alphora Research, Genoma Laboratory Group, Ana Laboratories Inc, Lifecodexx AG, Gatc Biotech AG, Japan Analytical Chemistry Consultants Co. Ltd. (''Jacc''), Tsing Hua and Ecopro Research K.K. (''Ecopro'') and Craft Technologies.
Company Coordinates 
Company Details
23 val Fleuri , LUXEMBOURG None : 1526
Registrar Details






